InvestorsHub Logo
Post# of 4973773
Next 10
Followers 39
Posts 7322
Boards Moderated 0
Alias Born 10/17/2013

Re: None

Monday, 10/03/2022 12:42:38 PM

Monday, October 03, 2022 12:42:38 PM

Post# of 4973773
pharnext: 0.0007
FR0011191287
52: 0.0005 - 0.47

BRIEF-Pharnext: Financing Agreement With Néovacs For EUR 20.7 Mln Net To Further Develop PXT3003

Oct 3 (Reuters) - Pharnext SA :
* PHARNEXT EXECUTES A FINANCING AGREEMENT WITH NÉOVACS FOR
EUR
20.7 MILLION NET TO FURTHER DEVELOP PXT3003 FOR
CHARCOT-MARIE-TOOTH DISEASE TYPE 1A
* CUMULATIVE FINANCING RESULTING FROM THESE AGREEMENTS
BRINGS A
TOTAL POTENTIALLY AVAILABLE NET AMOUNT OF APPROXIMATELY EUR 46.7
MILLION
* SUBJECT TO EACH PARTY'S SATISFYING ITS OBLIGATIONS,
CONSIDERS IT
WOULD BE ABLE TO FINANCE ITS OPERATIONS, PREMIER TRIAL UNTIL Q1
2024

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.